par C830 (Diltiazem Hydrochloride Extended-Release 180 mg)
Pill with imprint par C830 is Green / Blue, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release 180 mg. It is supplied by Par Pharmaceutical, Inc..
Diltiazem is used in the treatment of atrial fibrillation; atrial flutter; angina pectoris prophylaxis; heart failure; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par C830
Diltiazem Hydrochloride Extended-Release
- Imprint
- par C830
- Strength
- 180 mg
- Color
- Green / Blue
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group iv antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0830
- Inactive Ingredients
-
ammonio methacrylate copolymer type A,
ammonio methacrylate copolymer type B,
ammonia,
gelatin,
hydroxypropyl cellulose (type l),
propylene glycol,
shellac,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Green No. 3,
corn starch
Note: Inactive ingredients may vary.
More about diltiazem
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 145 Reviews
- Drug class: calcium channel blocking agents
Consumer resources
- Patient Information
- Diltiazem (Advanced Reading)
- Diltiazem Intravenous (Advanced Reading)
- Diltiazem Long-Acting Capsules
- Diltiazem 12-Hour Sustained-Release Capsules
- ... +3 more
- Other brands
- Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.